American Cancer Society Cancer Action Network (ACS CAN) released a voter guide that details where the two major candidates for Tennessee's United States Senate seat stand on three important federal policy issues that affect cancer prevention and treatment.
"We want voters to know before the election where the candidates stand on these issues," said Michael Holtz, ACS CAN state lead ambassador. "The future of cancer in Tennessee is so determined by what happens in the halls of Congress today. We are grateful that both Marsha Blackburn and Phil Bredesen answered our questions because it makes for a truly nonpartisan guide."
ACS CAN asked both candidates to respond to the following questions:
- If elected, will you vote for annual increases in cancer research funding for the National Institutes of Health and the National Cancer Institute?
- If elected, will you oppose any bills that allow insurers to deny coverage or charge higher premiums to people with pre-existing conditions, reinstitute lifetime or annual caps, and/or weaken essential health benefits such as coverage for prescription drugs?
- If elected, will you support public-private efforts to share what we've developed in the U.S. to eliminate worldwide death from cervical cancer by supporting U.S. investment in global health funding for cervical cancer prevention, screening and treatment?
Their responses are listed in full at https://www.fightcancer.org/voter-guides/tennessee